New York City-based Memorial Sloan Kettering Cancer Center has broken ground on a $2.3 billion inpatient facility, the Kenneth C. Griffin Pavilion. The new facility will be connected to the cancer center’s main hospital by a dedicated patient bridge, according…
Oncology
Milwaukee-based Medical College of Wisconsin received $27 million for the MCW Cancer Center from Tim and Barbara Michels and the Michels Family Foundation. A research facility will be renamed the Medical College of Wisconsin Michels Center for Cancer Discovery in…
A greater gap between an individual’s chronological and biological age is associated with a higher risk of developing early-onset cancer. Younger generations are aging faster biologically, according to a study published June 22 in Nature Medicine, a finding which researchers…
Boston-based Dana-Farber Cancer Institute recorded an operating income of $61.2 million (3% operating margin) in the first half of fiscal 2026, compared to an operating income of $61.5 million (3.2% margin) during the same period last year. Dana-Farber reported total…
The overall cancer death rate has fallen 35% since 1991, according to the American Association for Cancer Research’s “Cancer Disparities Progress Report 2026.” The improved cancer survival rate has contributed to a cancer survivor population of more than 18.6 million,…
Advertisement
One of the biggest challenges in cancer care delivery is getting harder to ignore, according to leaders who spoke at Becker’s Oncology Executive Summit in April. The geographic distribution of National Cancer Institute-designated cancer centers — the most research-intensive cancer…
On June 22, West Orange, N.J.-based RWJBarnabas Health and New Brunswick, N.J.-based Rutgers Cancer Institute opened the Melchiorre Cancer Center at Cooperman Barnabas Medical Center in Livingston, N.J. The cancer center cost $225 million, according to a June 23 news…
HHS has directed six of its agencies to reduce regulatory barriers associated with clinical trial research to accelerate pharmaceutical development in the U.S. The move — detailed in a road map called Operation TrailBlazer — comes as “a growing share…
Detroit-based Barbara Ann Karmanos Cancer Institute treated 15,754 new cancer cases in fiscal year 2025, marking a 47% increase in new cases since 2020. The increase marks the highest number of new cancer cases in a fiscal year in the…
The FDA approved 13 new immunotherapies in 2025, down from 22 approvals in 2024, according to the Cancer Research Institute “Cancer Immunotherapy Insights & Impact” report published June 1. The Cancer Research Institute tracks and analyzes FDA cancer immunotherapy approvals…